Egbert Scholtens

1.5k total citations
45 papers, 1.3k citations indexed

About

Egbert Scholtens is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Physiology. According to data from OpenAlex, Egbert Scholtens has authored 45 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Cardiology and Cardiovascular Medicine, 13 papers in Molecular Biology and 10 papers in Physiology. Recurrent topics in Egbert Scholtens's work include Cardiac electrophysiology and arrhythmias (10 papers), Drug Transport and Resistance Mechanisms (7 papers) and Nitric Oxide and Endothelin Effects (6 papers). Egbert Scholtens is often cited by papers focused on Cardiac electrophysiology and arrhythmias (10 papers), Drug Transport and Resistance Mechanisms (7 papers) and Nitric Oxide and Endothelin Effects (6 papers). Egbert Scholtens collaborates with scholars based in Netherlands, Germany and Canada. Egbert Scholtens's co-authors include Gerard J. Mulder, Wiek H. van Gilst, Klaas R. Krijgsheld, Henk Koster, H. Wesseling, K. Sandy Pang, Grietus Mulder, P. A. de Graeff, Dirk K. F. Meijer and G J Mulder and has published in prestigious journals such as Journal of the American College of Cardiology, Biochemical Journal and The FASEB Journal.

In The Last Decade

Egbert Scholtens

45 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Egbert Scholtens Netherlands 23 351 344 287 244 186 45 1.3k
C. Cojocel Germany 17 307 0.9× 279 0.8× 106 0.4× 109 0.4× 108 0.6× 46 921
N A Payne United States 17 264 0.8× 306 0.9× 121 0.4× 68 0.3× 149 0.8× 32 1.2k
Mahmoud Mansour Saudi Arabia 20 302 0.9× 168 0.5× 391 1.4× 194 0.8× 65 0.3× 62 1.8k
P Lettéron France 20 419 1.2× 63 0.2× 520 1.8× 217 0.9× 96 0.5× 30 1.4k
I. Bartošek Italy 17 267 0.8× 105 0.3× 163 0.6× 238 1.0× 70 0.4× 60 896
Fumio Takayama Japan 16 363 1.0× 139 0.4× 75 0.3× 136 0.6× 79 0.4× 26 1.1k
Pekka Uotila Finland 18 242 0.7× 177 0.5× 121 0.4× 68 0.3× 260 1.4× 101 1.4k
C Fisch France 17 434 1.2× 90 0.3× 363 1.3× 140 0.6× 62 0.3× 33 1.1k
Y. James Kang United States 20 486 1.4× 153 0.4× 165 0.6× 107 0.4× 97 0.5× 37 1.8k
Masaaki Soma Japan 19 395 1.1× 105 0.3× 104 0.4× 99 0.4× 160 0.9× 41 1.0k

Countries citing papers authored by Egbert Scholtens

Since Specialization
Citations

This map shows the geographic impact of Egbert Scholtens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Egbert Scholtens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Egbert Scholtens more than expected).

Fields of papers citing papers by Egbert Scholtens

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Egbert Scholtens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Egbert Scholtens. The network helps show where Egbert Scholtens may publish in the future.

Co-authorship network of co-authors of Egbert Scholtens

This figure shows the co-authorship network connecting the top 25 collaborators of Egbert Scholtens. A scholar is included among the top collaborators of Egbert Scholtens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Egbert Scholtens. Egbert Scholtens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Duarte, Ana, Egbert Scholtens, & Franz J. Weissing. (2012). Implications of Behavioral Architecture for the Evolution of Self-Organized Division of Labor. PLoS Computational Biology. 8(3). e1002430–e1002430. 13 indexed citations
2.
Boer, Rudolf A. de, et al.. (2003). Increased expression of cardiac angiotensin II type 1 (AT) receptors decreases myocardial microvessel density after experimental myocardial infarction. Cardiovascular Research. 57(2). 434–442. 50 indexed citations
3.
Teisman, Ard, Ben H.C. Westerink, Dirk J. van Veldhuisen, et al.. (2000). Direct interaction between the sympathetic and renin–angiotensin system in myocardial tissue: a microdialysis study in anaesthetised rats. Journal of the Autonomic Nervous System. 78(2-3). 117–121. 8 indexed citations
4.
Pinto, Yigal M., Hendrik Buikema, Wiek H. van Gilst, et al.. (1997). Cardiovascular end-organ damage in Ren-2 transgenic rats compared to spontaneously hypertensive rats. Journal of Molecular Medicine. 75(5). 371–377. 43 indexed citations
5.
Anthonio, Rutger L., et al.. (1997). Effects of Amlodipine on Endothelial Function in Rats with Chronic Heart Failure After Experimental Myocardial Infarction. Journal of Cardiovascular Pharmacology. 30(5). 683–689. 4 indexed citations
6.
Gilst, Wiek H. van, Dirk J. van Veldhuisen, Hendrik Buikema, et al.. (1994). Effect of Ibopamine on Ventricular Remodeling After Experimental Myocardial Infarction. Journal of Cardiovascular Pharmacology. 24(1). 171–174. 15 indexed citations
7.
Veldhuisen, Dirk J. van, Wiek H. van Gilst, Bart J.G.L. de Smet, et al.. (1994). Neurohumoral and hemodynamic effects of ibopamine in a rat model of chronic myocardial infarction and heart failure. Cardiovascular Drugs and Therapy. 8(2). 245–250. 8 indexed citations
8.
Buikema, Hendrik, Wiek H. van Gilst, D.J. van Veldhuisen, et al.. (1993). Endothelium dependent relaxation in two different models of chronic heart failure and the effect of ibopamine. Cardiovascular Research. 27(12). 2118–2124. 22 indexed citations
9.
Pinto, Y M, Wiek H. van Gilst, Egbert Scholtens, et al.. (1993). Selective and time related activation of the cardiac renin-angiotensin system after experimental heart failure: relation to ventricular function and morphology. Cardiovascular Research. 27(11). 1933–1938. 53 indexed citations
10.
Gilst, Wiek H. van, et al.. (1991). Converting Enzyme Inhibitors and the Role of the Sulfhydryl Group in the Potentiation of Exo- and Endogenous Nitrovasodilators. Journal of Cardiovascular Pharmacology. 18(3). 429–436. 40 indexed citations
11.
Gilst, Wiek H. van, Egbert Scholtens, Pieter A. de Graeff, & H. Wesseling. (1990). Coronary vasodilation by sulfhydryl-containing converting enzyme inhibitors is affected by the precursor of endothelium derived relaxing factor. Journal of the American College of Cardiology. 15(2). A21–A21. 2 indexed citations
12.
Gilst, Wiek H. van, et al.. (1988). Protective effects of captopril against ischemia/reperfusion-induced ventricular arrhythmias in vitro and in vivo. The American Journal of Medicine. 84(3). 67–74. 33 indexed citations
13.
Scholtens, Egbert & G J Mulder. (1983). A simple method of obtaining multiple blood samples from the portal vein and the hepatic vein in the rat in vivo. Cellular and Molecular Life Sciences. 39(10). 1176–1177. 9 indexed citations
14.
Pang, K. Sandy, et al.. (1983). Normal and retrograde perfusion to probe the zonal distribution of sulfation and glucuronidation activities of harmol in the perfused rat liver preparation.. Journal of Pharmacology and Experimental Therapeutics. 224(3). 647–653. 58 indexed citations
15.
Krijgsheld, Klaas R., et al.. (1982). Cholestatic effect of harmol glucuronide in the rat. Prevention of harmol-induced cholestasis by increased formation of harmol sulfate.. Journal of Pharmacology and Experimental Therapeutics. 221(3). 731–734. 13 indexed citations
16.
Mulder, Gerard J., Egbert Scholtens, & Dirk K. F. Meijer. (1981). [4] Collection of metabolites in bile and urine from the rat. Methods in enzymology on CD-ROM/Methods in enzymology. 77. 21–30. 41 indexed citations
17.
Pang, K. Sandy, et al.. (1981). Aberrant Pharmacokinetics of harmol in the perfused rat liver preparation: sulfate and glucuronide conjugations.. Journal of Pharmacology and Experimental Therapeutics. 219(1). 134–140. 48 indexed citations
18.
Scholtens, Egbert, et al.. (1980). Serum concentration of inorganic sulfate in mammals: Species differences and circadian rhythm. Comparative Biochemistry and Physiology Part A Physiology. 67(4). 683–686. 55 indexed citations
19.
Krijgsheld, Klaas R., et al.. (1979). Absorption, serum levels and urinary excretion of inorganic sulfate after oral administration of sodium sulfate in the conscious rat. Biochimica et Biophysica Acta (BBA) - General Subjects. 586(3). 492–500. 54 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C. Cojocel Breakdown of academic impact, for papers by N A Payne Breakdown of academic impact, for papers by Mahmoud Mansour Breakdown of academic impact, for papers by P Lettéron Breakdown of academic impact, for papers by I. Bartošek Breakdown of academic impact, for papers by Fumio Takayama Breakdown of academic impact, for papers by Pekka Uotila Breakdown of academic impact, for papers by C Fisch Breakdown of academic impact, for papers by Y. James Kang Breakdown of academic impact, for papers by Masaaki Soma
Rankless by CCL
2026